IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $129,000 | +55.4% | 4,661 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $83,000 | -25.2% | 4,561 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $111,000 | +42.3% | 4,561 | -43.8% | 0.00% | 0.0% |
| Q1 2019 | $78,000 | +8.3% | 8,118 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $72,000 | +24.1% | 8,118 | +58.6% | 0.00% | 0.0% |
| Q3 2018 | $58,000 | -47.7% | 5,118 | -41.1% | 0.00% | -50.0% |
| Q2 2018 | $111,000 | -53.6% | 8,696 | -38.6% | 0.00% | -33.3% |
| Q1 2018 | $239,000 | +1095.0% | 14,169 | +455.6% | 0.00% | – |
| Q4 2017 | $20,000 | -13.0% | 2,550 | -15.0% | 0.00% | – |
| Q3 2017 | $23,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |